BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boughton CK, Murphy KG. Can neuropeptides treat obesity? A review of neuropeptides and their potential role in the treatment of obesity. Br J Pharmacol 2013;170:1333-48. [PMID: 23121386 DOI: 10.1111/bph.12037] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Fernando HA, Zibellini J, Hsu MS, Seimon RV, Nguyen AD, Sainsbury A. The neuropeptide Y-ergic system: potential therapeutic target against bone loss with obesity treatments. Expert Review of Endocrinology & Metabolism 2014;10:177-91. [DOI: 10.1586/17446651.2015.1001741] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Alotibi MN, Alnoury AM, Alhozali AM. Serum nesfatin-1 and galanin concentrations in the adult with metabolic syndrome. Relationships to insulin resistance and obesity. Saudi Med J 2019;40:19-25. [PMID: 30617376 DOI: 10.15537/smj.2019.1.22825] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
3 Gáliková M, Klepsatel P, Xu Y, Kühnlein RP. The obesity-related Adipokinetic hormone controls feeding and expression of neuropeptide regulators of Drosophila metabolism: AKH controls feeding and neuropeptide expression. Eur J Lipid Sci Technol 2017;119:1600138. [DOI: 10.1002/ejlt.201600138] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 4.8] [Reference Citation Analysis]
4 da Fonseca ACP, Mastronardi C, Johar A, Arcos-burgos M, Paz-filho G. Genetics of non-syndromic childhood obesity and the use of high-throughput DNA sequencing technologies. Journal of Diabetes and its Complications 2017;31:1549-61. [DOI: 10.1016/j.jdiacomp.2017.04.026] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
5 Meneguetti BT, Cardoso MH, Ribeiro CF, Felício MR, Pinto IB, Santos NC, Carvalho CM, Franco OL. Neuropeptide receptors as potential pharmacological targets for obesity. Pharmacology & Therapeutics 2019;196:59-78. [DOI: 10.1016/j.pharmthera.2018.11.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
6 Huvenne H, Dubern B, Clément K, Poitou C. Rare Genetic Forms of Obesity: Clinical Approach and Current Treatments in 2016. Obes Facts 2016;9:158-73. [PMID: 27241181 DOI: 10.1159/000445061] [Cited by in Crossref: 77] [Cited by in F6Publishing: 64] [Article Influence: 12.8] [Reference Citation Analysis]
7 Keeble J. The background to this themed issue on neuropeptides. Br J Pharmacol 2013;170:1277-8. [PMID: 24236898 DOI: 10.1111/bph.12474] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Simoes E, Correia-Lima J, Calfat ELB, Otani TZDS, Vasques DAC, Otani VHO, Bertolazzi P, Kochi C, Seelaender M, Uchida RR. Sex-Dependent Dyslipidemia and Neuro-Humoral Alterations Leading to Further Cardiovascular Risk in Juvenile Obesity. Front Nutr 2020;7:613301. [PMID: 33644105 DOI: 10.3389/fnut.2020.613301] [Reference Citation Analysis]
9 Sherwood A, Holland PC, Adamantidis A, Johnson AW. Deletion of Melanin Concentrating Hormone Receptor-1 disrupts overeating in the presence of food cues. Physiology & Behavior 2015;152:402-7. [DOI: 10.1016/j.physbeh.2015.05.037] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
10 Cron L, Allen T, Febbraio MA. The role of gp130 receptor cytokines in the regulation of metabolic homeostasis. J Exp Biol 2016;219:259-65. [PMID: 26792338 DOI: 10.1242/jeb.129213] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
11 Erdos B, Backes I, McCowan ML, Hayward LF, Scheuer DA. Brain-derived neurotrophic factor modulates angiotensin signaling in the hypothalamus to increase blood pressure in rats. Am J Physiol Heart Circ Physiol 2015;308:H612-22. [PMID: 25576628 DOI: 10.1152/ajpheart.00776.2014] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
12 Merlino DJ, Blomain ES, Aing AS, Waldman SA. Gut-Brain Endocrine Axes in Weight Regulation and Obesity Pharmacotherapy. J Clin Med 2014;3:763-94. [PMID: 26237477 DOI: 10.3390/jcm3030763] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
13 Poulimeneas D, Yannakoulia M, Anastasiou CA, Scarmeas N. Weight Loss Maintenance: Have We Missed the Brain? Brain Sci 2018;8:E174. [PMID: 30208568 DOI: 10.3390/brainsci8090174] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
14 Apovian CM, Garvey WT, Ryan DH. Challenging obesity: Patient, provider, and expert perspectives on the roles of available and emerging nonsurgical therapies. Obesity (Silver Spring) 2015;23 Suppl 2:S1-S26. [PMID: 26154880 DOI: 10.1002/oby.21140] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
15 Moreno E, Quiroz C, Rea W, Cai NS, Mallol J, Cortés A, Lluís C, Canela EI, Casadó V, Ferré S. Functional μ-Opioid-Galanin Receptor Heteromers in the Ventral Tegmental Area. J Neurosci 2017;37:1176-86. [PMID: 28007761 DOI: 10.1523/JNEUROSCI.2442-16.2016] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
16 Wölk E, Stengel A, Schaper SJ, Rose M, Hofmann T. Neurotensin and Xenin Show Positive Correlations With Perceived Stress, Anxiety, Depressiveness and Eating Disorder Symptoms in Female Obese Patients. Front Behav Neurosci 2021;15:629729. [PMID: 33664656 DOI: 10.3389/fnbeh.2021.629729] [Reference Citation Analysis]
17 Romano A, Gallelli CA, Koczwara JB, Braegger FE, Vitalone A, Falchi M, Micioni Di Bonaventura MV, Cifani C, Cassano T, Lutz TA, Gaetani S. Role of the area postrema in the hypophagic effects of oleoylethanolamide. Pharmacol Res 2017;122:20-34. [PMID: 28535974 DOI: 10.1016/j.phrs.2017.05.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
18 Suh JH, Wang Y, Ho CT. Natural Dietary Products and Their Effects on Appetite Control. J Agric Food Chem 2018;66:36-9. [PMID: 29237125 DOI: 10.1021/acs.jafc.7b05104] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
19 Yi X, Kabanov AV. Brain delivery of proteins via their fatty acid and block copolymer modifications. J Drug Target 2013;21:940-55. [PMID: 24160902 DOI: 10.3109/1061186X.2013.847098] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
20 Ahmad A, Almsned F, Ghazal P, Ahmed MW, Jafri MS, Bokhari H. Neuropeptide S receptor gene Asn107 polymorphism in obese male individuals in Pakistan. PLoS One 2020;15:e0243205. [PMID: 33332443 DOI: 10.1371/journal.pone.0243205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Huvenne H, Le Beyec J, Pépin D, Alili R, Kherchiche PP, Jeannic E, Frelut ML, Lacorte JM, Nicolino M, Viard A, Laville M, Ledoux S, Tounian P, Poitou C, Dubern B, Clément K. Seven novel deleterious LEPR mutations found in early-onset obesity: a ΔExon6-8 shared by subjects from Reunion Island, France, suggests a founder effect. J Clin Endocrinol Metab 2015;100:E757-66. [PMID: 25751111 DOI: 10.1210/jc.2015-1036] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]